S&P 500   2,969.48 (-0.03%)
DOW   26,837.99 (+0.08%)
QQQ   191.43 (+0.17%)
AAPL   237.55 (+0.57%)
MSFT   139.93 (+0.18%)
AMZN   1,727.17 (-0.27%)
NVDA   185.74 (-0.13%)
GE   8.69 (-1.36%)
T   37.49 (-0.24%)
PRI   121.25 (-0.36%)
NFLX   283.79 (+0.30%)
BAC   29.00 (+0.31%)
DIS   129.74 (-0.22%)
S&P 500   2,969.48 (-0.03%)
DOW   26,837.99 (+0.08%)
QQQ   191.43 (+0.17%)
AAPL   237.55 (+0.57%)
MSFT   139.93 (+0.18%)
AMZN   1,727.17 (-0.27%)
NVDA   185.74 (-0.13%)
GE   8.69 (-1.36%)
T   37.49 (-0.24%)
PRI   121.25 (-0.36%)
NFLX   283.79 (+0.30%)
BAC   29.00 (+0.31%)
DIS   129.74 (-0.22%)
Log in

ProtoKinetix News Headlines (OTCMKTS:PKTX)

$0.13
0.00 (0.00 %)
(As of 10/14/2019 11:13 AM ET)
Today's Range
$0.13
Now: $0.13
$0.13
50-Day Range
$0.09
MA: $0.14
$0.21
52-Week Range
$0.05
Now: $0.13
$0.32
Volume171 shs
Average Volume151,843 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

ProtoKinetix (OTCMKTS PKTX) News Headlines

Source:
DateHeadline
Tests Show AAGP® Preserved and Enabled Retinal Cells to Mature Without Compromise after 5-Month MilestoneTests Show AAGP® Preserved and Enabled Retinal Cells to Mature Without Compromise after 5-Month Milestone
finance.yahoo.com - August 23 at 10:31 AM
ProtoKinetix Reaches Mid-Point of 3rd Stage of Retinal Cell Replacement Therapy Testing at UBCProtoKinetix Reaches Mid-Point of 3rd Stage of Retinal Cell Replacement Therapy Testing at UBC
finance.yahoo.com - July 9 at 10:30 AM
ProtoKinetix Achieves Primary Objective Safety at Midpoint of Clinical TrialProtoKinetix Achieves Primary Objective Safety at Midpoint of Clinical Trial
finance.yahoo.com - June 7 at 6:50 PM
ProtoKinetix First in Series of Town Hall Shareholder MeetingsProtoKinetix First in Series of Town Hall Shareholder Meetings
finance.yahoo.com - May 30 at 5:07 PM
Agreement Secured by ProtoKinetix to Start Heart Research Product Validation StudiesAgreement Secured by ProtoKinetix to Start Heart Research Product Validation Studies
finance.yahoo.com - May 9 at 10:25 AM
ProtoKinetix Releases Third in a Series of Scientific Update VideosProtoKinetix Releases Third in a Series of Scientific Update Videos
finance.yahoo.com - February 26 at 11:04 AM
ProtoKinetix Releases Second in a Series of Scientific Update VideosProtoKinetix Releases Second in a Series of Scientific Update Videos
finance.yahoo.com - January 16 at 10:07 AM
ProtoKinetix Releases First in a Series of Scientific Update VideosProtoKinetix Releases First in a Series of Scientific Update Videos
finance.yahoo.com - December 19 at 10:18 AM
ProtoKinetix Begins Cardiovascular ResearchProtoKinetix Begins Cardiovascular Research
finance.yahoo.com - September 28 at 9:52 AM
ProtoKinetix Enters into 3rd Phase of Retinal Cell Replacement Therapy Testing at UBCProtoKinetix Enters into 3rd Phase of Retinal Cell Replacement Therapy Testing at UBC
finance.yahoo.com - August 10 at 3:56 PM
PKTX Shares Hit 52-Week High On Signing of Material Transfer Agreement with an International Biotech CompanyPKTX Shares Hit 52-Week High On Signing of Material Transfer Agreement with an International Biotech Company
www.baystreet.ca - June 13 at 3:58 PM
ProtoKinetix’s AAGP® Signs a Material Transfer Agreement with a Reputed International Biotech CompanyProtoKinetix’s AAGP® Signs a Material Transfer Agreement with a Reputed International Biotech Company
finance.yahoo.com - June 13 at 9:47 AM
ProtoKinetix Has Entered into a Research Agreement with The University of British Columbia to Test the Effect of its AAGP™ on Monoclonal Antibody Production and Bone Marrow RecoveryProtoKinetix Has Entered into a Research Agreement with The University of British Columbia to Test the Effect of its AAGP™ on Monoclonal Antibody Production and Bone Marrow Recovery
finance.yahoo.com - January 10 at 10:18 AM
The Effects of ProtoKinetix’ Anti-Aging Glycopeptide (AAGP™) on Immune Cell Banking and Functions Relevant to ImmunotherapyThe Effects of ProtoKinetix’ Anti-Aging Glycopeptide (AAGP™) on Immune Cell Banking and Functions Relevant to Immunotherapy
finance.yahoo.com - November 18 at 10:57 AM
This page was last updated on 10/14/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel